RecruitingNCT04699292
International Prospective Registry on Local Treatment Approaches in MLS
International Prospective Registry on Local Treatment Approaches in Myxoid Liposarcomas
Sponsor
The Netherlands Cancer Institute
Enrollment
300 participants
Start Date
Jan 18, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Age \> 18 years
- Biopsy proven MLS, including the reciprocal chromosomal translocation t(12;16)(q13;p11)
- ECOG PS 0-2
- Written informed consent to share coded information in this international Registry
Exclusion Criteria2
- Prior radiotherapy to the target area
- Pregnancy
Interventions
PROCEDURESurgery
Surgery
RADIATIONPreoperative RT 36Gy
Preoperative radiotherapy to 36Gy (equivalent)
RADIATIONPreoperative RT 50Gy
Preoperative radiotherapy to 50Gy (equivalent)
RADIATIONPostoperative RT 50-66Gy
Postoperative radiotherapy to 50-66Gy (equivalent)
RADIATIONRT 36Gy
Definitive radiotherapy to 36Gy (equivalent)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04699292